Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:14 PM
Ignite Modification Date:
2025-12-24 @ 12:14 PM
NCT ID:
NCT03530761
Eligibility Criteria:
Inclusion Criteria:
* Patients with liver cirrhosis diagnosed as acute kidney injury or hepatorenal syndrome
* Patients who voluntarily agreed to the study
Exclusion Criteria:
* Patients with active bleeding (eg, varix bleeding) within 7 days
* Patients with hepatocellular carcinoma
* Patients with hypersensitivity to terlipressin
* Patients with anuria
* Pregnant and lactating patients
* Patients who did not agree with the study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT03530761
Study Brief:
Protocol Section:
NCT03530761